SWIFT-seq uses single-cell sequencing to profile CTCs, offering a noninvasive alternative to bone marrow biopsies for MM diagnosis and monitoring. The method provides comprehensive genomic and ...

Multiple myeloma diagnosis integrates blood tests, genetic assessments, and imaging to guide personalized treatment and patient engagement. Smoldering multiple myeloma involves active surveillance to ...

Stage 2 multiple myeloma involves intermediate cancer levels, requiring treatment for symptoms like bone issues, anemia, and kidney problems. Diagnosis includes blood, urine, imaging tests, and ...

Diane Davis thought a diagnosis of advanced ovarian cancer was the answer she had been looking for. For months, she had been sick. Antibiotics were no help. When she went to the emergency room, a CT ...

New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead, lifespan-linked genes and cross-trait scores hold the real clues to prognosis.